N
NXTM

Nuveen’s NxStage Medical Inc. NXTM Stock Holding History

Nuveen’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-136,174
Closed -$3.41M – 1192
2017
Q2 		$3.41M Buy
136,174
+24,818
+22% +$614K 0.02% 532
2017
Q1 		$2.99M Sell
111,356
-202,198
-64% -$5.59M 0.02% 596
2016
Q4 		$8.22M Buy
313,554
+23,084
+8% +$571K 0.04% 511
2016
Q3 		$7.26M Sell
290,470
-163,213
-36% -$3.81M 0.04% 463
2016
Q2 		$9.84M Buy
453,683
+117,628
+35% +$2.1M 0.06% 355
2016
Q1 		$5.04K Buy
336,055
+33,974
+11% +$569K 0.03% 476
2015
Q4 		$6.62K Sell
302,081
-163,709
-35% -$3.05M 0.03% 412
2015
Q3 		$7.34K Buy
465,790
+54,110
+13% +$867K 0.04% 395
2015
Q2 		$5.88K Buy
411,680
+66,310
+19% +$1.12M 0.03% 493
2015
Q1 		$5.97M Sell
345,370
-22,305
-6% -$394K 0.03% 484
2014
Q4 		$6.59M Sell
367,675
-50,912
-12% -$820K 0.04% 480
2014
Q3 		$5.5M Sell
418,587
-116,343
-22% -$1.57M 0.03% 522
2014
Q2 		$7.69M Sell
534,930
-8,372
-2% -$109K 0.05% 434
2014
Q1 		$6.92M Buy
543,302
+395,752
+268% +$5.16M 0.04% 436
2013
Q4 		$1.48M Sell
147,550
-51,429
-26% -$584K 0.01% 902
2013
Q3 		$2.62M Buy
198,979
+32,839
+20% +$431K 0.02% 696
2013
Q2 		$2.37M Buy
+166,140
New +$2.09M 0.02% 702

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Nuveen's NXTM Position: Q3 2017 in Review

Nuveen sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 136,174 shares — an estimated $3.41M sold.

Nuveen first reported a position in NXTM in Q2 2013 and held it in 17 quarters. The position peaked at $9.84M in Q2 2016. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

  • Nuveen reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
  • Nuveen sold 136,174 NxStage Medical Inc. shares in Q3 2017, an estimated $3.41M.
  • Nuveen first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 17 quarters.
  • Nuveen's NxStage Medical Inc. position peaked at $9.84M in Q2 2016.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Nuveen's 13F filing for Q3 2017, filed 14 Nov 2017.